Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Provider News

February New Resource Roundup

February 5, 2025

New Gastroenterology and Hepatology eConsult Orders Available

The division of Gastroenterology and Hepatology has added two additional options for eConsult orders:

  1. Liver Enzyme Abnormalities/Hyperbilirubinemia
  2. Unspecified Question for Gastroenterology

An eConsult is a non-urgent asynchronous electronic consultation request initiated by a community provider to a Seattle Children’s specialist. It allows community providers to receive timely, efficient care guidance on lower-complexity and data-oriented clinical questions that may not require an in-person evaluation. eConsults will be submitted using EpicCare Link, which is available to all providers regardless of what EHR is used in their clinic. Learn more and request access to EpicCare Link.

CME Recordings

Dr. Steven Lee, Division Chief of Pediatric General and Thoracic Surgery presented on Common Pediatric Surgical Conditions: Updates and Management in January and the recording is now available.

Recent Grand Rounds Recordings Available

Seattle Children's hosts grand rounds on a weekly basis. Here are some recent talks we think may be of interest:

Seattle Children’s Study Finds CAR T Cells Safe, ‘Encouraging’ Against Lethal Brain Cancer

Ben Towne Center for Childhood Cancer and Blood Disorders Research's Dr. Nick Vitanza and colleagues published findings about a first-in-human phase I trial using engineered immune cells to battle diffuse intrinsic pontine glioma. Three patients — all of whom began the CAR T treatment prior to disease progression — are still alive, with two of them still receiving CAR T cells years beyond their diagnosis.